[Form 4] Associated Banc-Corp Insider Trading Activity
Nicole M. Kitowski, Executive Vice President of Associated Banc-Corp (ASB), is the reporting person on this Form 4. The filing discloses a transaction dated 08/15/2025 in which shares of the issuer's common stock were acquired through the company’s Employee Stock Purchase Plan.
The Form shows an acquisition of 29.242 shares at a purchase price of $25.079 per share and indicates 45,032.2636 shares beneficially owned following the transaction. The filing also reports an indirect holding of 3,164 shares through a 401(k) plan. The Form was signed by an attorney-in-fact on behalf of Ms. Kitowski on 08/18/2025.
- Insider purchase disclosed: Executive Vice President acquired shares under the ESPP, showing participation in company equity programs.
- Complete disclosure: Form 4 includes transaction date, shares acquired, price, post-transaction beneficial ownership and signature by attorney-in-fact.
- None.
Insights
TL;DR: Officer purchase via ESPP shows insider participation but is routine and non-derivative.
This Form 4 reports a small, routine acquisition under the issuer's Employee Stock Purchase Plan. The disclosed 29.242 share purchase at $25.079 is a non-derivative transaction and therefore represents direct insider buying activity rather than option exercise or derivative trades. The reported post-transaction beneficial ownership of 45,032.2636 shares provides a snapshot of the officer's stake but does not, by itself, indicate a material change in control or ownership percentage. For investors, such ESPP purchases typically reflect participation in company compensation programs rather than signaling major strategic moves.
TL;DR: Filing is procedurally complete and documents ESPP acquisition; no governance red flags noted.
The Form 4 includes required details: reporting person identity, relationship to issuer (Executive Vice President), transaction date, number of shares acquired, and price. The explanation clarifies the transaction arose from the Employee Stock Purchase Plan, and the form bears an attorney-in-fact signature. There are no indications of unusual timing, derivative use, or disposal of shares that would raise governance or compliance concerns. The disclosure appears consistent with routine insider reporting obligations.